Cryoport Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Cryoport şirketinin toplam hissedar öz sermayesi $418.6M ve toplam borcu $199.3M olup, bu da borç-öz sermaye oranını 47.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $701.8M ve $283.2M dir.

Anahtar bilgiler

47.6%

Borç/özkaynak oranı

US$199.29m

Borç

Faiz karşılama oranı	n/a
Nakit	US$272.67m
Eşitlik	US$418.57m
Toplam yükümlülükler	US$283.19m
Toplam varlıklar	US$701.77m

Son finansal sağlık güncellemeleri

Recent updates

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Nov 06

The Market Lifts Cryoport, Inc. (NASDAQ:CYRX) Shares 36% But It Can Do More

Aug 09

Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Jul 22

Slammed 28% Cryoport, Inc. (NASDAQ:CYRX) Screens Well Here But There Might Be A Catch

Jun 25

Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk

Apr 15

Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Mar 15

Cryoport Tanks On Chilling Results And Bad Decisions

Mar 14

Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Mar 10

Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)

Jan 15

Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Oct 06

Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term

Jul 23

Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity

Jul 12

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Jun 13

Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price

Mar 06

Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially

Nov 07

Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Sep 23

Cryoport: A Rare Investing Opportunity

Sep 22

Cryoport enters into strategic relationship with Takeda's BioLife Plasma Services

Sep 08

Cryoport: Rapid Growth Is Great, But Shares Look Overpriced

Jul 30

Cryoport: To Resume Aggressive Growth

May 11

Cryoport: An Industry Leader Basking In Industry Tailwinds

Apr 15

Cryoport: Risky Investment With Upside Potential

Apr 01

Cryoport: More Growth Going Into New Year 2022

Dec 29

Is Cryoport, Inc. (NASDAQ:CYRX) Trading At A 49% Discount?

Dec 05

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: CYRX 'nin kısa vadeli varlıkları ( $350.3M ) kısa vadeli yükümlülüklerini ( $61.4M ) aşıyor.

Uzun Vadeli Yükümlülükler: CYRX şirketinin kısa vadeli varlıkları ( $350.3M ) uzun vadeli yükümlülüklerini ( $221.8M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: CYRX şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: CYRX şirketinin borç/öz sermaye oranı son 5 yılda 13.4% seviyesinden 47.6% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: CYRX şirketinin mevcut serbest nakit akışına göre 3 yıldan fazla bir süre için yeterli nakit pistine sahip olduğu belirtiliyor.

Tahmini Nakit Akışı: CYRX, serbest nakit akışı her yıl % 30.6 oranında tarihi oranda azalmaya devam ederse 3 yıldan fazla bir süre yeterli nakit akışına sahip olur

Cryoport Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Recent updates

Chairman notifies of intention to sell stock

Consensus EPS estimates upgraded to US$1.85 loss

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Consensus EPS estimates fall by 44%

The Market Lifts Cryoport, Inc. (NASDAQ:CYRX) Shares 36% But It Can Do More

Price target decreased by 23% to US$12.75

Second quarter 2024 earnings: EPS misses analyst expectations

Cryoport, Inc. (NasdaqCM:CYRX) announces an Equity Buyback for $200 million worth of its shares.

New major risk - Share price stability

Cryoport, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Slammed 28% Cryoport, Inc. (NASDAQ:CYRX) Screens Well Here But There Might Be A Catch

Independent Lead Director recently sold US$109k worth of stock

Consensus EPS estimates fall by 14%

First quarter 2024 earnings: EPS and revenues miss analyst expectations

Cryoport, Inc. Reiterates Revenue Guidance for the Full Year 2024

Cryoport, Inc. to Report Q1, 2024 Results on May 07, 2024

Potential Upside For Cryoport, Inc. (NASDAQ:CYRX) Not Without Risk

Cryoport, Inc., Annual General Meeting, May 17, 2024

Insufficient new directors

Consensus EPS estimates fall by 26%

Chairman notifies of intention to sell stock

Cryoport, Inc. (NASDAQ:CYRX) Just Reported Yearly Earnings: Have Analysts Changed Their Mind On The Stock?

Cryoport Tanks On Chilling Results And Bad Decisions

Cryoport, Inc. Announces Goodwill Impairment for the Quarter Ended December 31, 2023

Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Cryoport, Inc. to Report Q4, 2023 Results on Mar 12, 2024

Cryoport, Inc. Announces Transition of Edward Zecchini from the Board of Directors to Sr. Vice President - Chief Digital & Technology Officer

Fewer Investors Than Expected Jumping On Cryoport, Inc. (NASDAQ:CYRX)

Cryoport, Inc. (NasdaqCM:CYRX) acquired Bluebird Express LLC.

New minor risk - Share price stability

Cryoport, Inc. Provides Revenue Guidance for the Year 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Cryoport, Inc. (NasdaqCM:CYRX) acquired Tec4Med Lifescience GmbH.

Cryoport, Inc. to Report Q3, 2023 Results on Nov 08, 2023

Health Check: How Prudently Does Cryoport (NASDAQ:CYRX) Use Debt?

Chairman notifies of intention to sell stock

Consensus EPS estimates fall by 35%

New major risk - Revenue and earnings growth

Second quarter 2023 earnings: EPS misses analyst expectations

Cryoport, Inc. to Report Q2, 2023 Results on Aug 09, 2023

Downgrade: Here's How Analysts See Cryoport, Inc. (NASDAQ:CYRX) Performing In The Near Term

Consensus EPS estimates fall by 19%

Price target decreased by 17% to US$25.75

Cryoport, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2023

Cryoport, Inc.'s (NASDAQ:CYRX) Subdued P/S Might Signal An Opportunity

Is Cryoport (NASDAQ:CYRX) A Risky Investment?

Independent Lead Director recently sold US$155k worth of stock

Consensus EPS estimates upgraded to US$0.66 loss

First quarter 2023 earnings: EPS exceeds analyst expectations

Cryoport, Inc. Provides Revenue Guidance for the Year 2023

Chairman recently sold US$54k worth of stock

Cryoport, Inc.'s (NASDAQ:CYRX) Intrinsic Value Is Potentially 96% Above Its Share Price

Consensus EPS estimates fall by 54%, revenue upgraded

Full year 2022 earnings: EPS misses analyst expectations

No longer forecast to breakeven

Cryoport, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Forecast to breakeven in 2025

Independent Lead Director recently sold US$142k worth of stock

Consensus EPS estimates fall by 12%

Consensus EPS estimates fall by 10%

Cryoport, Inc. (NASDAQ:CYRX) Analysts Just Cut Their EPS Forecasts Substantially

Third quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to US$46.11

Cryoport, Inc. Revises Revenue Guidance for the Year 2022

Cryoport, Inc. to Report Q3, 2022 Results on Nov 03, 2022

Is Cryoport (NASDAQ:CYRX) Using Debt In A Risky Way?

Cryoport: A Rare Investing Opportunity